Compare NVAX & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | WEN |
|---|---|---|
| Founded | 1987 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1996 | 1999 |
| Metric | NVAX | WEN |
|---|---|---|
| Price | $10.09 | $7.05 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 22 |
| Target Price | ★ $11.33 | $8.88 |
| AVG Volume (30 Days) | 4.2M | ★ 9.0M |
| Earning Date | 05-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.81% |
| EPS Growth | ★ 309.76 | N/A |
| EPS | ★ 2.58 | 0.85 |
| Revenue | $1,123,479,000.00 | ★ $2,176,891,000.00 |
| Revenue This Year | N/A | $2.44 |
| Revenue Next Year | N/A | $0.99 |
| P/E Ratio | ★ $3.97 | $8.47 |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $5.01 | $6.73 |
| 52 Week High | $11.85 | $15.51 |
| Indicator | NVAX | WEN |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 39.71 |
| Support Level | $7.81 | $6.73 |
| Resistance Level | $10.42 | $8.74 |
| Average True Range (ATR) | 0.73 | 0.29 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 36.18 | 25.00 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.